Skip to content

The impact of transcranial direct current stimulation-assisted esketamine-based opioid-sparing general anesthesia on postoperative acute pain in orthopedic patients.

The impact of transcranial direct current stimulation-assisted esketamine-based opioid-sparing general anesthesia on postoperative acute pain in orthopedic patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096474
Enrollment
Unknown
Registered
2025-01-24
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative acute pain

Interventions

C group:Conventional General Anesthesia
D group:tDCS stimulation
K group:adjunctive intravenous use of esketamine
DK group:adjunctive intravenous use of esketamine+tDCS stimulation

Sponsors

Xuzhou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.> = age 60 years; 2. Elective orthopedic surgery under general anesthesia, 1 = operation time =4h; 3. ASA grade II-III; 4. No communication barriers, clear consciousness; 5. BMI of 18.5-28 kg/m2; 6. Voluntary use of postoperative intravenous analgesic devices; 7. In line with ethics, the patient voluntarily underwent the test and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Those who have contraindications or allergies to esketamine and other anesthetic drugs; 2. Identify/suspect those who have abused or used narcotic sedative analgesics for a long time; 3. Patients with severe hypertension and severe cardiovascular disease; 4. Any cerebrovascular accident within 3 months; 5. Patients with pulmonary hypertension, intracranial pressure or intraocular hypertension; 6. Those with a history of severe mental illness, central nervous system injury or cognitive dysfunction; 7. Patients with severe liver and kidney insufficiency; 8. History of use of antidepressant and other psychotropic drugs; 9. Pregnant; 10. Implantation of pacemakers or other metals in the body; 11. Refusal to sign informed consent.

Design outcomes

Primary

MeasureTime frame
Postoperative 24-hour pain score;

Secondary

MeasureTime frame
Postoperative 48-hour pain score;Postoperative 72-hour pain score;Post-extubation pain score;Post-anesthesia recovery room awakening quality evaluation; Postoperative adverse reactions;

Countries

China

Contacts

Public ContactLiwei Wang

Xuzhou Central Hospital

doctorIww@sina.com+86 189 5217 0255

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026